SEMULOPARIN FOR USE AS AN ANTITHROMBOTIC TREATMENT IN HIP REPLACEMENT SURGERY WITH IMPROVED SAFETY IN TERMS OF CLINICALLY RELEVANT BLEEDINGS AND MAJOR BLEEDINGS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13712450

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof as an antithrombotic treatment in patients undergoing hip replacement surgery, wherein said use involves an improved safety in terms of clinically relevant bleedings and of major bleedings compared to a standard antithrombotic treatment.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVENTIS PHARMA S A20 AVENUE RAYMOND ARON ANTONY CEDEX FRANCE 92165

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DESTREE, Dominique Paris, FR 4 0
JEAN, DE POTTER Chantal Paris, FR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • A61K Class
  • 0 % this patent is cited more than
  • 12 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges93340159383591527830328862201 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +025050075010001250150017502000225025002750300032503500375040004250

Forward Cite Landscape

Load Citation